Ever Source Wealth Advisors, LLC Travere Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 147 shares of TVTX stock, worth $2,892. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147Holding current value
$2,892% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$150 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$145 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$133 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$97.9 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$83.8 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.26B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...